רקטוג'סיק  इसराइल - हिब्रू - Ministry of Health

רקטוג'סיק

padagis israel agencies ltd, israel - glyceryl trinitrate - משחה - glyceryl trinitrate 0.4 % - glyceryl trinitrate - glyceryl trinitrate - for relief of pain associated with chronic anal fissure. in the clinical development of the drug a modest effect has shown on improvement in average daily pain intensity.

טרנדייט טבליות 200 מג इसराइल - हिब्रू - Ministry of Health

טרנדייט טבליות 200 מג

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 200 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

אלפו-קל XL इसराइल - हिब्रू - Ministry of Health

אלפו-קל xl

padagis israel agencies ltd, israel - alfuzosin hydrochloride - טבליות בשחרור ממושך - alfuzosin hydrochloride 10 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason.

אלטרוקסין טבליות 100 מקג इसराइल - हिब्रू - Ministry of Health

אלטרוקסין טבליות 100 מקג

padagis israel agencies ltd, israel - levothyroxine sodium - טבליה - levothyroxine sodium 100 mcg - levothyroxine sodium - levothyroxine sodium - treatment of hypothyroidism, cretinism and juvenile myoedema.

אלטרוקסין טבליות  50 מקג इसराइल - हिब्रू - Ministry of Health

אלטרוקסין טבליות 50 מקג

padagis israel agencies ltd, israel - levothyroxine sodium - טבליה - levothyroxine sodium 0.05 mg - levothyroxine sodium - levothyroxine sodium - treatment of hypothyroidism. cretinism and juvenile myxoedema.

אלקראן טבליות 2 מג इसराइल - हिब्रू - Ministry of Health

אלקראן טבליות 2 מג

padagis israel agencies ltd, israel - melphalan - טבליה - melphalan 2 mg - melphalan - melphalan - for the palliative treatment of multiple myeloma and of non-epithelial carcinoma of the ovary.

טמו 5 מג इसराइल - हिब्रू - Ministry of Health

טמו 5 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 5 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 5 מג इसराइल - हिब्रू - Ministry of Health

טמו 5 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 5 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 20 מג इसराइल - हिब्रू - Ministry of Health

טמו 20 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 20 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

טמו 20 מג इसराइल - हिब्रू - Ministry of Health

טמו 20 מג

padagis israel agencies ltd, israel - temozolomide - קפסולות - temozolomide 20 mg - temozolomide - temozolomide - temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.